Shopping Cart
Remove All
Your shopping cart is currently empty
Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $58 | - | In Stock | |
| 5 mg | $133 | - | In Stock | |
| 10 mg | $198 | - | In Stock | |
| 25 mg | $343 | - | In Stock | |
| 50 mg | $513 | - | In Stock | |
| 100 mg | $746 | - | In Stock | |
| 500 mg | $1,560 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $133 | - | In Stock |
| Description | Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes. |
| Targets&IC50 | TAOK2:1.1 µM, MMP9:0.52 μM |
| Molecular Weight | 394.9 |
| Formula | C16H15ClN4O2S2 |
| Cas No. | 333746-76-2 |
| Smiles | CC1=C(C=2N=C(NC3=C(OC)C=CC(Cl)=C3)SC2)SC(NC(C)=O)=N1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (126.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.